Competing to Raise Greater Awareness of Clinical Trials

Clare Grace
Vice President, Site and Patient Access
July 14, 2016

By now you have likely heard about INC Research and CISCRP soliciting #ideas4patients to identify innovate new ways our industry can raise greater awareness of clinical trials and boost patient participation.

But what you may not know is how we are leveraging these ideas to really make an impact. The Ideathon is a new style of event that involves rapidly solving a problem with a large group of people in an innovative and competitive style. These types of events are utilized quite extensively in the technology industries and amongst entrepreneurial groups, but they haven’t been used very widely to solve challenges in clinical research. The goal of the Ideathon is to build a community of problem solvers who are interested in making a difference to the broader community and can bring unique perspectives to the table. Now through August 8th, we are encouraging healthcare professionals and contributors from across the industry to generate new and unique ways to help raise awareness of clinical trials and study participation. A panel of judges will evaluate the submissions based on the following criteria:

  • Innovation - How 'innovative' is the idea? Is this idea creative and progressive?
  • Feasibility of Implementation - How feasible is the idea? How can it be executed within 6 months/one year on a defined budget?
  • Sustainability - How sustainable is the idea? Is this idea cost-effective? Where does this have market potential and scalability?
  • Impact - How does this idea raise awareness for diverse or vulnerable populations in a range of disease and medical conditions?

Shortlisted finalists will be notified week commencing August 15, 2016 and will be invited to the Ideathon event on September 27-28, 2016 in Boston.

This is our chance to work together as a team to make a difference in the success of clinical trials. Clinical research is vital to the development of new drugs and treatments and is entirely dependent on the people who volunteer to participate in studies, but less than 5% of people actually take part. It’s critical that we work together as an industry to encourage participation – I look forward to reviewing YOUR ideas!